Skip to main content
. 2022 Mar 1;5(3):e220625. doi: 10.1001/jamanetworkopen.2022.0625

Table 2. Risk of Bias Among Randomized Clinical Trials.

Source Risk of biasa
Randomization process Deviations from intended interventions Missing outcome data Measurement of the outcome Selection of the reported result Overall
Shakur et al,2 2010 Low Low Low Low Low Low
Guyette et al,3 2020 Low Low Low Low Some concerns Some concerns
Rowell et al,4 2020 Low Low Low Low Some concerns Some concerns
CRASH-3 trial collaborators,13 2019 Low Low Low Low Low Low
Chakroun-Walha et al,14 2019 Low Some concerns Low Low Some concerns Some concerns
Yutthakasemsunt et al,15 2013 Low Low Low Low Some concerns Some concerns

Abbreviation: CRASH-3, Clinical Randomisation of an Antifibrinolytic in Significant Head Injury.

a

Assessed using the Cochrane Risk of Bias 2 tool.5,6